Profil

DE PRIJCK Bernard

Département de médecine interne > Service d'hématologie clinique

See author's contact details
Main Referenced Co-authors
Beguin, Yves  (32)
Bonnet, Christophe  (22)
Baron, Frédéric  (15)
Caers, Jo  (12)
Fillet, Georges  (10)
Main Referenced Keywords
Humans (5); Adult (3); Aged (3); Middle Aged (3); Hematopoietic Stem Cell Transplantation (2);
Main Referenced Disciplines
Hematology (39)
Radiology, nuclear medicine & imaging (2)
Dermatology (1)
Endocrinology, metabolism & nutrition (1)
Laboratory medicine & medical technology (1)

Publications (total 46)

The most downloaded
10966 downloads
Jaspers, A., Baron, F., Bonnet, C., De Prijck, B., Fassotte, M.-F., & Beguin, Y. (2010). Le lymphome du manteau. Revue Médicale de Liège, 65, 171-176. https://hdl.handle.net/2268/80188

The most cited

45 citations (Scopus®)

Herens, C., Tassin, F., Lemaire, V., Beguin, Y., Collard, E., Lampertz, S., Croisiau, C., Desouter-Lecomte, M., DE PRIJCK, B., Longree, L., & Koulischer, L. (2000). Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. British Journal of Haematology, 110 (1), 214-6. doi:10.1046/j.1365-2141.2000.02142.x https://hdl.handle.net/2268/8044

MAQUET, C., DE PRIJCK, B., JASPERS, A., Tassin, F., Keutgens, A., Beguin, Y., & De Voeght, A. (May 2024). Front-line venetoclax monotherapy for blastic plasmacytoid dendritric cell neoplasm. Belgian Journal of Hematology, 15 (3), 125-129.
Peer Reviewed verified by ORBi

Bailleux, S., SOMJA, J., MARTIN, M., DE PRIJCK, B., & NIKKELS, A. (2022). HEREDITARY LEIOMYOMATOSIS AND ACUTE LYMPHOBLASTIC LEUKEMIA: a LINK THROUGH FUMARATE DYSHYDRATASE MUTATION? Acta Clinica Belgica, 77, 778-781. doi:10.1080/17843286.2021.1980669
Peer Reviewed verified by ORBi

LETE, C., FERNANDEZ CARAZO, R., MENTEN, C., BECKERS, P., KOOPMANSCH, B., FRANKE, S., DE PRIJCK, B., JAMAR, M., LAMBERT, F., & BOURS, V. (July 2021). A case of early-T-cell precursor acute lymphoblastic leukemia with e6a2 BCR-ABL1 fusion transcript [Poster presentation]. 13th European Cytogenomics Conference.

MAQUET, C., BEGUIN, Y., DE PRIJCK, B., WILLEMS, E., SERVAIS, S., & BONNET, C. (2021). Le lymphome diffus à grandes cellules B : nouveau traitement révolutionnaire par des cellules immunitaires génétiquement modifiées appelées «CAR T cells». Revue Médicale de Liège, 76, 476-481.
Peer reviewed

Trimech, M., Letourneau, A., Missiaglia, E., DE PRIJCK, B., Nagy-Hulliger, M., SOMJA, J., Vivario, M., Gaulard, P., LAMBERT, F., Bisig, B., & de Leval, L. (2021). Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome. American Journal of Surgical Pathology, 45, 773-786. doi:10.1097/PAS.0000000000001646
Peer Reviewed verified by ORBi

DE VOEGHT, A., JASPERS, A., BEGUIN, Y., Baron, F., & DE PRIJCK, B. (2021). Principes généraux de la prise en charges des leucémies aiguës de l’adulte en 2021 en Belgique. Revue Médicale de Liège, 76, 470-475.
Peer reviewed

WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600
Peer Reviewed verified by ORBi

Vrancken, L., Muller, J., Lejeune, M., Grégoire, C., Delens, L., Jaspers, A., Servais, S., DE PRIJCK, B., Baron, F., Caers, J., & Beguin, Y. (2018). Nouveautes dans la prise en charge du myelome. Revue Médicale Suisse, 14 (615), 1438-1442.
Peer Reviewed verified by ORBi

Vekemans, M.-C., Beel, K., CAERS, J., Meuleman, N., Bries, G., Demuynck, H., DE PRIJCK, B., De Samblanx, H., Deweweirea, A., Fostier, K., Mineur, P., Vaes, M., Vande Broeck, I., Vande Velde, A., Van Droogenbroeck, J., Vlummers, P., Wu, K.-L., Schots, R., Delforge, M., & Doyen, C. (2017). Update on therapy of relapsed and refractory multiple myeloma. Belgian Journal of Hematology, 8, 53-65.
Peer Reviewed verified by ORBi

WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845
Peer Reviewed verified by ORBi

SID, S., Baron, F., WILLEMS, E., Caers, J., Bonnet, C., DE PRIJCK, B., LEJEUNE, M., HAFRAOUI, K., Servais, S., JASPERS, A., & Beguin, Y. (November 2016). Hematologic recovery after autologus stem cell transplantation in multiple myeloma: a single center experience of 225 patients [Paper presentation]. 16ème Congrès commun de la SFGM-TC & 8ème de la SFBCT, Liège, Belgium.

WITHOFS, N., COUSIN, F., TANCREDI, T., SIMONI, P., DE PRIJCK, B., HAFRAOUI, K., BONNET, C., HUSTINX, R., BEGUIN, Y., & CAERS, J. (14 June 2016). Comparison of combined whole-body 18F-NAF and 18F-FDG PET/CT versus MRI for the detection of myeloma lesions [Paper presentation]. SNMMI 2016 Annual Meeting.

JASPERS, A., Baron, F., Maertens, J., DE PRIJCK, B., Schots, R., Bonnet, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & Beguin, Y. (July 2015). Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation [letter to the editor]. American Journal of Hematology, 90 (7), 133-4. doi:10.1002/ajh.24013
Peer Reviewed verified by ORBi

BONNET, C., Janssens, A., Wu, K., Schroyens, W., Van Hende, V., Heimann, P., Tousseyn, T., André, M., Bron, D., Van Hoof, A., Verhoef, G., DE PRIJCK, B., Beguin, Y., & Dierickx, D. (2015). BHS guidelines for the treatment of Burkitt lymphoma. Belgian Journal of Hematology, 6 (2), 61-69.
Peer Reviewed verified by ORBi

SID, S., Dugauquier, C., DE PRIJCK, B., BONNET, C., & Beguin, Y. (2015). Haemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 6 (2), 74-78.
Peer Reviewed verified by ORBi

JASPERS, A., BARON, F., MAERTENS, J., DE PRIJCK, B., SCHOTS, H., BONNET, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & BEGUIN, Y. (December 2014). Long-term safety follow-up of a rendomized trial of Darbepoetin Alpha and intravenous iron following autologous hematopoietic cell transplantation. Blood, 124 (21), 3948.
Peer Reviewed verified by ORBi

VALDES SOCIN, H. G., Potorac, I., DE PASQUAL, A., BARON, F., DE PRIJCK, B., Beguin, Y., & Beckers, A. (2014). Leucémie myéloblastique aiguë : sécrétion paranéoplasique de GH et de PRL ? In Abstract book - Annales d'Endocrinologie : 31ème Congrès de la Société Françaose d'Endocrinologie, Lyon 5-8 novembre 2014.

SID, S., Dugauquier, D., DE PRIJCK, B., Bonnet, C., & Beguin, Y. (2014). Hemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 17-18.
Peer Reviewed verified by ORBi

André, M., DE PRIJCK, B., Kentos, A., Van Hoof, A., Bonnet, C., Sonet, A., Maerevoet, M., Van Den Neste, E., Bosly, A., & Mounier, N. (2014). ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III - IV low risk Hodgkin Lymphoma (IPS 0-2): final results of LYSA H34 trial. Belgian Journal of Hematology, 12.
Peer Reviewed verified by ORBi

DE PRIJCK, B., HAYETTE, M.-P., & MISTRETTA, V. (19 December 2013). Alliance diagnostique et thérapeutique contre les mycoses invasives [Paper presentation]. Formation continue de Biologie Clinique, Liège, Belgium.

CAERS, J., Vekemans, M.-C., Bries, G., Beel, K., Delrieu, V., Deweweire, A., Demuynck, H., DE PRIJCK, B., De Samblanx, H., Kentos, A., Meuleman, N., Mineur, P., Offner, F., Vande Broek, I., Van Droogenbroeck, J., Vande Velde, A., Wu, K.-L., Delforge, M., Schots, R., & Doyen, C. (September 2013). Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians. Annals of Medicine, 45, 413-422. doi:10.3109/07853890.2013.801562
Peer Reviewed verified by ORBi

HAFRAOUI, K., DE PRIJCK, B., & Beguin, Y. (2013). Leucémie myélomonocytaire chronique : diagnostic et thérapeutique. Revue Médicale Suisse, 9, 1512-1517.
Peer Reviewed verified by ORBi

COLLINS, P., Vijgen, S., DE PRIJCK, B., BLETARD, N., Beguin, Y., & Delvenne, P. (2013). Chimiothérapie, immunodépression et cancers secondaires : rapport d'un cas clinique. Revue Médicale de Liège, 67, 418-422.
Peer reviewed

Van Obbergh, F., Van Hoof, A., Verhoef, G., Dierickx, D., De Wilde, V., Offner, F., Bron, D., Sonet, A., André, M., Janssens, A., Bonnet, C., DE PRIJCK, B., Zachée, P., Kentos, A., Schroyens, W., & Van Den Neste, E. (2013). Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS). Belgian Journal of Hematology, 4 (3), 90-101.
Peer Reviewed verified by ORBi

BEGUIN, Y., Maertens, J., DE PRIJCK, B., Schots, R., Seidel, L., BONNET, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., SERVAIS, S., JASPERS, A., FILLET, G., & BARON, F. (2013). Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial. American Journal of Hematology, 88, 990-996. doi:10.1002/ajh.23552
Peer Reviewed verified by ORBi

FRUSCH, N., SERVAIS, S., DE PRIJCK, B., Corhay, J.-L., Beguin, Y., Louis, R., & DUYSINX, B. (2012). Spontaneous pneumomediastinum caused by bleomycin-induced pneumonitis. Acta Clinica Belgica, 67-68. doi:10.2143/ACB.67.5.2062693
Peer Reviewed verified by ORBi

Malaise, O., FRUSCH, N., BECK, E., Servais, S., BETEA, D., CAERS, J., DE PRIJCK, B., & BEGUIN, Y. (2012). Panhypopituitarism and diabetus insipidus in a patient with primary central nervous system lymphoma. Leukemia and Lymphoma, 53 (12), 2515-16.
Peer Reviewed verified by ORBi

Bonnet, C., DE PRIJCK, B., LEJEUNE, M., FASSOTTE, M.-F., Van Den Neste, E., & Beguin, Y. (2012). Prise en charge du lymphome B diffus à grandes cellules en 2012. Revue Médicale Suisse, 8, 1582-90.
Peer Reviewed verified by ORBi

Phan-Ba, R., Bisig, B., Deprez, M., DE PRIJCK, B., DELRUE, G., HERENS, C., Moonen, G., Belachew, S., & de Leval, L. (June 2011). Primary central nervous system lymphoma in a patient treated with Natalizumab. Annals of Neurology, 69 (6), 1060-1. doi:10.1002/ana.22296
Peer Reviewed verified by ORBi

CAERS, J., BONNET, C., GRAUX, C., DE PRIJCK, B., & BEGUIN, Y. (2011). Prise en charge actuelle des syndromes myélodysplasiques. Revue Médicale Suisse, 7, 1634-1643.
Peer Reviewed verified by ORBi

Bonnet, C., CAERS, J., DE PRIJCK, B., HAFRAOUI, K., & Beguin, Y. (2011). Lymphome du manteau : prise en charge 2011. Revue Médicale Suisse, 7, 1644-1649.
Peer Reviewed verified by ORBi

Schots, R., Delforge, M., André, M., Bries, G., CAERS, J., Demuynck, H., DE PRIJCK, B., De Samblanx, H., Kentos, A., Meuleman, N., Offner, F., Vekemans, M., Vande Broek, I., Van Droogenbroeck, J., Van de Velde, A., Wu, K., & Doyen, C. (2010). The Belgian 2010 consensus recommendations for the treatment of multiple myeloma. Acta Clinica Belgica, 65, 252-264. doi:10.1179/acb.2010.055
Peer Reviewed verified by ORBi

Jaspers, A., Baron, F., Bonnet, C., De Prijck, B., Fassotte, M.-F., & Beguin, Y. (2010). Le lymphome du manteau. Revue Médicale de Liège, 65, 171-176.
Peer reviewed

Servais, S., Caers, J., Warling, O., Frusch, N., Baron, F., De Prijck, B., & Beguin, Y. (2010). Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma. British Journal of Haematology, 150 (3), 379-381. doi:10.1111/j.1365-2141.2010.08202.x
Peer Reviewed verified by ORBi

Bonnet, C., Beguin, Y., De Prijck, B., Witvrouw, N., Hustinx, R., & Fillet, G. (2009). Les anticorps monoclonaux en hématologie en 2009. Revue Médicale de Liège, 64, 268-273.
Peer reviewed

Beguin, Y., Maertens, J., DE PRIJCK, B., Schots, R., Frère, P., Bonnet, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., LEJEUNE, M., SERVAIS, S., THeunissen, K., Fillet, G., & Baron, F. (2009). A prospective randomized multicenter trial of darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation [Poster presentation]. 24th General Meeting of the Belgian Hematological Society, Oostende, Belgium.

Dugauquier, C., Bataille, Y., Willems, E., Frere, P., De Prijck, B., Beguin, Y., & Baron, F. (2009). Toxoplasmore cérébrale compliquant une mini-allogreffe de cellules souches hématopoïétiques du sang périphérique. Revue Médicale de Liège, 64 (7-8), 366-369.
Peer reviewed

Bonnet, C., Beguin, Y., De Prijck, B., de Leval, L., & Fillet, G. (2009). Traitements actuels du lymphome folliculaire. Revue Médicale Suisse, 5, 1663-7.
Peer Reviewed verified by ORBi

GULBIS, B., FERSTER, A., VERMYLEN, C., DRESSE, M.-F., VANDERFAEILLIE, A., DELANNOY, A., LABARQUE, V., PHILIPPET, P., KENTOS, A., SZTERN, B., DE PRIJCK, B., & VERTONGEN, F. (2008). An estimation of the incidence and demographic picture of the major hemoglobinopathies in Belgium (from a confidential inquiry). Hemoglobin, 32 (3), 279-85. doi:10.1080/03630260802004400
Peer Reviewed verified by ORBi

Hustinx, R., Jerusalem, G., & De Prijck, B. (2008). Tomographie à émission de positons et lymphomes. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 32, 449-455. doi:10.1016/j.mednuc.2008.06.002
Peer Reviewed verified by ORBi

Witvrouw, N., De Prijck, B., & Hustinx, R. (2008). Indications cliniques de la radiotherapie metabolique dans les lymphomes. Revue Médicale Suisse, 4 (168), 1818-22.
Peer Reviewed verified by ORBi

Lejeune, M., Beguin, Y., De Prijck, B., Fassotte, M.-F., Fillet, G., & Baron, F. (2008). Comment je traite...La leucémie myéloblastique aiguë (LMA) du sujet age en bon état général. Revue Médicale de Liège, 63 (2), 59-63.
Peer reviewed

De Prijck, B., Baron, F., Beguin, Y., Bonnet, C., Willems, E., & Fillet, G. (2007). Actualités thérapeutiques en hématologie. Revue Médicale de Liège, 62 (5-6), 384-90.
Peer reviewed

Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Herens, C., De Prijck, B., Fillet, G., & Beguin, Y. (2003). Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC. Bone Marrow Transplantation, 32 (8), 829-34. doi:10.1038/sj.bmt.1704220
Peer Reviewed verified by ORBi

Bonnet, C., Fillet, G., Bosly, A., Van Hoof, A., Offner, F., Van Den Neste, E., DE PRIJCK, B., Deflandre, A., Gisselbrecht, C., & Reyes, F. (2003). Radiotherapy is unnecessary in elderly patients with localized aggressive non hodgkin's lymphoma: results of the LNH 93-4 study [Paper presentation]. 18th General Meeting of the Belgian Hematological Society, Brussels, Belgium.

Herens, C., Tassin, F., Lemaire, V., Beguin, Y., Collard, E., Lampertz, S., Croisiau, C., Desouter-Lecomte, M., DE PRIJCK, B., Longree, L., & Koulischer, L. (2000). Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. British Journal of Haematology, 110 (1), 214-6. doi:10.1046/j.1365-2141.2000.02142.x
Peer Reviewed verified by ORBi

Contact ORBi